Cardiotoxicity | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

325 results for “Cardiotoxicity”

Trials

View all 245 →

Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes

20 participants · First posted Apr 2, 2014

Vascular Cardiotoxicity of Ponatinib

32 participants · First posted Apr 29, 2019

Cardiotoxicity in the Elderly

110 participants · First posted Jun 11, 2019

Drugs

Uridine triacetate(Vistogard, Xuriden)

Conditions: Orotic aciduria, Capecitabine overdose +1 more

C₁₅H₁₈N₂O₉

News

View all 79 →

Continuous OCR Monitoring Detects Mitochondrial Cardiotoxicity Before Visible Cell Damage

Auckland Researchers Launch Clinical Trial to Investigate 5FU Chemotherapy Cardiotoxicity

Moleculin's Annamycin Shows 36% Complete Response Rate in AML Phase 1B/2 Trial with Zero Cardiotoxicity

Page 1 of 33